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Murine B cell stimulatory factors have been defined using T cell tumors, hybrid-
omas, cell lines, or clones as the source. These factors, such as IL-4, IL-5, and IL-6,
each have distinct effects on B cells. The effects of IL-4 on B cells include enhanced
expression of MHC class II molecules, costimulation of anti-Ig induced DNA syn-
thesis, induced expression of a low-affinity Fc, receptor, and isotype switching to
IgGl and IgE secretion (1, 2). IL-5 costimulates dextran sulfate-induced B cell prolifer-
ation and promotes Ig secretion of preactivated B cells (3). IL-6 stimulates growth
and Ig secretion of B cell lines (2). An additional B cell growth factor, referred to
as BCGF, maintains the growth of anti-Ig-preactivated B cells (4, 5).
The production of defined B cell stimulatory factors by antigen-activated normal
T cells has not been analyzed. T cells activated in an MLR produce T cell growth
factors as well as helper factors for antigen-dependent responses (6, 7). In this study,
we use bioassays and neutralizing mAbs to demonstrate that IL-2, IL-4, and BCGF
are among the lymphokines produced during the primary and secondary MLR.
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Mice.
￿
Mice of either sex were used at 8-12 wk of age. BALB/c x DBA/2 F, (CxD2F, ;H-
2d), C57BL/6 x DBA2 F, (B6xD2F, ;H-2bxd), and C57BL/6 congenic for H-2k (B6.H-2k) were
purchased from Trudeau Institute, Saranac Lake, NY.
Cells.
￿
Dendritic cells (DC) were prepared from spleen low density cells (8). T cells were
nylon wool nonadherent la- , spleen, and mesenteric lymph node cells, and were enriched
for CD4' T cells by depleting CD8' cells with anti-Lyt-2.2 (HO-2.2, American Type Cul-
ture Collection [ATCC] TIB 150) and complement (C, Pel-Freez Biologicals, Rogers, AR)
(6, 7). To enrich for CD8' cells, CD4' cells were depleted with GK1.5 anti-CD4 (ATCC;
TIB 207) and C. Splenic B cells were depleted of T cells with mAb and C, and adherent
cells by passage through Sephadex G-10. These B cells were further fractionated where indi-
cated by Percoll density gradient centrifugation to yield small B cells of a density >1.08 g/ml.
Anti-Ig-activated B lymphoblasts were prepared by stimulating purified high density or total
B cells with 5 Ng/ml anti-Ig-Sepharose for 2-3 d and are referred to as anti-Ig blasts. Blasts
were isolated, free of Sepharose beads, on Ficoll-Hypaque.
Culture Conditionsfor theMLR.
￿
Culture medium was RPMI 1640 supplemented with an-
tibiotic/antimycotic, 10% FCS, and 50 gM 2-ME. 5 x 105 , 5 x 106, or 5 x 102 T cells were
seeded in 0.2-ml microcultures, 1-ml macrocultures, or 10-ml cultures (upright in 25-cm2
T flasks), respectively. Stimulator DC, B cells, or anti-Ig blasts were irradiated (117C) and
added to a constant number ofT cellsat the ratios indicated. Clusters ofDC and responding
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T lymphocytes were isolated from 48-h macro or bulk cultures by velocity sedimentation
on Percoll gradients (6). Clusters that contained the antigen-reactive T cells were recultured
at 2-6 x 105/ml in 1 or 10 ml cultures for an additional 48 h; i.e., 48-96 h of the 1° MLR.
Supernatants were harvested at the indicated time points and assayed forlymphokines. Simul-
taneously, 100-wl aliquots of the resuspended cultures were transferred to microtiter wells
and pulsed for 8 h with 1 R Ci/well [3H]thymidine.
For the 2° MLR, T blasts were generated by DC-T clusters, isolated at 48 h of the primary
MLR, and recultured until 96 h. The blasts were separated from residual clusters (6) and
then depleted of residual Ia' stimulator cells and contaminating CD4' or CD8' T cells with
mAb and C. T blasts were recultured at 2-5 x 105/ml with the various irradiated stimu-
lator populations at the indicated ratios.
Lymphokines.
￿
Recombinant human IL-2 (r-huIL-2) was provided by Dr. S. Rudnick (Bio-
gen, Cambridge, MA). r-muIL-4 was purified on an 111111 anti-IL-4 (provided by Dr. E. S.
Vitetta, Dallas, TX) affinity column from the conditioned medium of an IL-4-transferred
HeLa cell line (provided by Dr. T. Honjo, Kyoto, Japan).
Lymphokine Assays.
￿
IL-4.IL-4 was detected by two different bioassays using r-muIL-4 as
a positive control in both cases. One was the costimulation assay in which IL-4 and anti-Ig
together induce [3H]TdR incorporation in high density or unfructionated murine B cells as
described (9). The identity of the active factor was confirmed by inhibiting the response with
2-10 ug/ml 11BIl anti-IL-4 mAb (10). The second bioassay was the growth of the CTLL cell
line seeded at 5 x 103 cells per well in a final volume of 100 pl. Although CTLL is used for
IL-2 bioassays, our cell line also responds to r-muIL-4. The maximal proliferative response
ofCTLL cellsto rIL-4 was much lower than the maximal response to rIL-2, but was specifically
inhibited by 11B11 anti-IL-4 and not by S4B6 anti-IL-2.
IL-2.
￿
IL-2 was detected by its ability to maintain the growth of CTLL cells. Inhibition
by the anti-IL-2 mAb S4B6 (11) (provided by Dr. T Mossman, DNAX, Palo Alto, CA) was
used to distinguish the contribution ofmurine IL-2 and other possible T cell growth factors that
might register in this assay. r-huIL-2 was used as a positive control.
BCGFAssay.
￿
Anti-Ig-activated B lymphoblasts proliferate and secrete Ig in response to
reculture in the presence of T cell-derived lymphokines distinct from IL-1, 2, 3, and 4 (4).
An ammonium sulfate fraction (50-85%) ofconditioned medium from PMA-stimulated EL-4
cells was used as a positive control. We have recently determined that neither purified natural
IL-5 (provided by Drs. D. MacKenzie and S. Swain, UCSD, University of California, San
Diego, CA) nor rIL-5 (present in the supernatant of IL-5 COS cell transfectants) alone can
substitute for EL-4 Sn in this assay (E. Pure, unpublished results). We refer to this activity
as BCGE The response induced by EL-4 Sri or MLR Sri in this assay was inhibited by at
most 20% by anti-IL-2 or anti-IL-4 or both, confirming that the factor(s) detected by the
growth of preactivated anti-19 blasts is distinct from IL-2 or IL-4.
Results and Discussion
Kinetics ofIL-2, IL-4, and BCGF Production by CD4' Tcells in the MLR.
￿
IL-2 was
consistently detected in the media of a 1° MLR as early as 4 h (Fig. 1 A). IL-2 levels
increased for the first48 h and remained high for at least 96 h. S4B6 anti-IL-2 com-
pletely inhibited the CTLL response to MLR medium collected during the first 2
d, but the mAb blocked only 40-60% at later time points. Incomplete inhibition
oflater supernatants could be due to the production of IL-2 in excess ofthe amount
that could be neutralized by the dose of S4B6 used, or another T cell growth factor.
Since 11BIl anti-IL-4 had no effect when the 1° MLR Sri was tested on CTLL, and
inhibition by 11B11 plus S4B6 was similar to S4B6 alone, the S4116-resistant activity
cannot be attributed to IL-4 . T blasts were isolated from the 1° MLR and restimu-
lated with fresh DC in a 2° MLR. Large quantities of IL-2, maximal by 12 h, were
detectable in the medium of this 2° MLR (Fig. 1 A, rightpanel). S4B6 blocked much
of this activity and 111111 enhanced the block.i
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FIGURE 1.
￿
IL-2, IL-4, and BCGF production by CD4' T cells during the 1° and 2° MLR.
5 x 106/ml CxD2Fl CD4* T cellswere cultured "in bulk" with 5 x 104 B6.H-2k DC in 1 ml
for48 h. Clusters were harvested and recultured at 5 x 105/ml. T blasts were harvested at 96 h
and restimulated at 5 x 105/mlwith 104 DC or 5 x 104anti-Ig blasts in the 2° MLR. Cell-free
supernatants were harvestedat theindicatedtimes, and 100 pl aliquots of resuspended cells from
the same wellswere transferred to microtiter wells to be pulsed with 1 RCi [3H]TdR for 8 h to
measure proliferation. [3H]TdR incorporation (cpm)with DC stimulation was: 4h, 1,687; 8 h,
1,222; 16 h, 1,539; 24 h, 4,002; 48 h, 14,590; 60 h, 22,200; 72 h, 50,690; and 96 h, 96,220 in
the 1° MLR. Response to DC in the2° MLRwasat 10 h, 9,132and24 h, 22,560;to restimulation
with anti-Ig blasts at 10 h, 17,650 and 24 h, 19,940; and unstimulated at 10 h, 3,289 and24 h,
470. 11B11 anti-IL-4 was addedwhereindicated at 2 Wg/mlandS4B6 anti-IL-2 culturesupernatant
at 25%. (A)CTLL growth assayof MLRsupernatants. (B) Anti-Ig costimulation assayofMLR
supernatants. (C) BCGF assay of MLR supernatant on anti-Ig preactivated blasts.
The anti-Igcostimulation assay, in contrast tothe CTLL assaywhich is an insen-
sitive measure of IL-4, detected IL-4 in the 1° MLR Sn. Activity was first noted
after the first day and was present for the remainder of the 96 h (Fig. 1 B). The
maximal amount of IL-4 detected in the 1° MLR, by comparison with the dose-
response curve obtained with r-muIL-4, was 2-10 U/ml in three experiments. The
quantityofIL-4 was markedlyhigher in the 2° MLR Sin(Fig. 1 B), reaching apeak
of 100 U/ml by 12 h. The activity ofthe 1° and 2° MLR media in the anti-Ig IL-4
costimulation assay was completely inhibited by 11B11 anti-IL-4 (Fig. 1 B) but was
decreased by at most 20% by S4B6 anti-IL-2 (data not shown).
Finally, MLR supernatants were assayed forBCGF activity on preactivated anti-
Ig blasts (Fig. 1 C). BCGF was found in small but detectable quantities by 24 h798
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in the 1° MLR (Fig. 1 C, left panel). In contrast to IL-4, the BCGFactivity increased
throughout the next 72 h (Fig. 1 C, center panel). Large quantities of BCGF, com-
parable with those found late during the 1° MLR, were detected in the conditioned
media by 12 h ofthe 2° MLR (Fig. 1 C, rightpanel). The response ofanti-Igpreacti-
vated blasts was not inhibited at all by 11B11 and at most by 20% in the presence
of S4B6 (not shown).
Lymphokine production required T cell stimulation in the MLR. First, the in-
duction oflymphokineswas blocked by mAbtothe MHC class II antigens expressed
on the stimulator population. The mAb did not interfere with the lymphokine bio-
assays. Second, in all experiments, supernatants from control cultures ofstimulator
cells alone or fresh responder T cells alone lacked detectable levels of IL-2, IL-4,
or BCGF.
The low levels ofIL-4 detected in the conditioned medium ofthe primary MLR
may either reflect low levels of production, rapid consumption by the activated T
cells that may use IL-4 as a growth factor (12), or the production offactors, for ex-
ample IFN -1', that inhibit IL-4 activity in the assay.
Comparison ofIL-4 and BCGF Production by CD8' and CD4+ TBlasts.
￿
Inaba et al.
(7) have reported that allogeneic DC induced the release ofIL-2 by both CD4' and
CD8+ lymphocyte subsets. We therefore assayed the conditioned medium from Lyt-
2 - (CD4+) or L3T4 - (CD8') MLRs for IL-4 and BCGF activity (Fig. 2). Condi-
tioned medium from CD4' cultures contained IL-4 (Fig. 2 A) and BCGF (Fig. 2
B) by 24 h with maximal levels at 48 h (Fig. 2). The production ofIL-4 and BCGF
was inhibited by the presence of anti-L3T4 antibody during the MLR (data not
shown). In contrast, only low levels of IL-4 and BCGF activity were detected in the
conditioned media of the CD8+ MLR (Fig. 2).
Efficacy ofAllogeneic DC, B Cells, andAnti-Ig Blasts as Stimulators ofLymphokine Produc-
tion. DC were the most efficient inducers ofIL-2, IL-4, and BCGF in the 1° MLR
of CD4' T cells. However, anti-Ig blasts also induced high levels of lymphokine
production. Both cell types induced T cell proliferation. In contrast, B cells were
weak or inactive in stimulating the growth of allogeneic T cells, as well as lym-
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FIGURE 2.
￿
5 x 106 CD4' (Lyt-2 - ) or CD8' (L3T4- ) CxD2F1 T cells were stimulated with
5 x 104 B6xD2F1 DC in 1 ml. The cell-free culture supernatants were harvested at the indi-
catedtimesand assayed for(A) IL-4 activity in theanti-Igcostimulation assay. (B)BCGF activity
on anti-Ig preactivated blasts.PURE ET AL .
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FIGURE 3 .
￿
Identification ofIL-4 and IL-2 in the 2° MLR-conditioned medium . CxD2F1 CD4`
T blasts were restimulated by B6.h-2kDC or48-h anti-Ig blasts as in Fig. 1 . At 24 h, themedium
was taken and assayed for IL-4 in the anti-Ig costimulation assay (A) and in the CTLL assay
(B) . IL-4 and IL-2 activities were confirmed by comparing the responses in the presence or ab-
sence of 2 gg/ml 111311 anti-IL-4, 25% S4B6 anti-IL-2 culture supernatant, or both .
phokine production (data not shown) . The pattern of stimulation in the 2° MLR
was different . Small B cells didinduce IL-2, IL-4, andBCGF production by allogeneic
T blasts, although they were less efficient then anti-Ig blasts or DC (Fig. 3 and data
not shown) . Consistent with the reported irradiation sensitivity ofB cell accessory
function (13), treatment with 3,000 rad blocked the capacity ofB cells, but not anti-
Ig blasts or DC, to induce lymphokine release (data not shown) . Interestingly, anti-
Ig blasts were reproducibly as, or more, effectivethan DC at stimulatinglymphokine
production in the 2° MLR (Fig. 3) .
Summary
Although the production ofB cell stimulatory factors by cell lines and hybridomas
is well established, production of specific lymphokinesby normal T cells in response
to antigen stimulationhasnotbeen analyzed . We have used bioassays andneutralizing
mAbs to demonstrate that IL-2, IL-4, and B cell growth factors (BCGF) are pro-
duced during primary and secondary MLRs. IL-2 is detected in the first 12 h of
both types ofMLR. IL-4 andBCGF appear at 24-48 h in the conditioned medium
of the primary MLR, and peak by 12 h in the secondary MLR. The amount of
IL-4 in the primary response reaches a level that is 10% of that detected in the sec-
ondary. In contrast, BCGF production steadily increases over time in the primary
MLR, andmaximal production is equivalent to that made in the secondary response .
Allogeneic dendritic cellsand anti-Ig-activated B blasts both stimulated lymphokine
production in theprimary MLR, whereas small B cellswere weak . In the secondary
MLR, all three cell populations stimulated the production of IL-2, IL-4, andBCGF.
Therefore, the release of several defined B cell stimulating factors can be detected
in the conditioned media of responding primary T lymphocytes .800
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